tradingkey.logo

Sensus Healthcare Inc

SRTS
View Detailed Chart
3.690USD
+0.210+6.03%
Close 11/05, 16:00ETQuotes delayed by 15 min
60.66MMarket Cap
LossP/E TTM

Sensus Healthcare Inc

3.690
+0.210+6.03%
Intraday
1m
30m
1h
D
W
M
D

Today

+6.03%

5 Days

+14.95%

1 Month

+7.58%

6 Months

-9.34%

Year to Date

-46.68%

1 Year

-43.66%

View Detailed Chart

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Sensus Healthcare Inc's Score

Industry at a Glance

Industry Ranking
92 / 210
Overall Ranking
205 / 4616
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
7.500
Target Price
+115.52%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Sensus Healthcare Inc Highlights

StrengthsRisks
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
Growing
The company is in a growing phase, with the latest annual income totaling USD 41.81M.
Undervalued
The company’s latest PE is -71.02, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 4.81M shares, decreasing 19.37% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 250.13K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.03.

Sensus Healthcare Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Sensus Healthcare Inc Info

Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
Ticker SymbolSRTS
CompanySensus Healthcare Inc
CEOMr. Joseph C. Sardano
Websitehttps://sensushealthcare.com/
KeyAI